NKTR : Summary for Nektar Therapeutics - Yahoo Finance

Canadian Markets close in 2 hrs 5 mins

Nektar Therapeutics (NKTR)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
18.91-0.02 (-0.11%)
As of 1:54PM EDT. Market open.
People also watch
NBIXALKSMDCOPGNXSGEN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close18.93
Open19.00
Bid18.93 x 400
Ask18.96 x 200
Day's Range18.74 - 19.28
52 Week Range11.41 - 24.88
Volume277,552
Avg. Volume2,117,316
Market Cap2.91B
Beta2.31
PE Ratio (TTM)-17.19
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Biotech Surge: How To Survive In A Volatile Market
    Investor's Business Daily5 hours ago

    Biotech Surge: How To Survive In A Volatile Market

    Biotech stocks have made big gains in 2017, but not all companies are winners.

  • PR Newswire8 days ago

    Nektar Therapeutics to Host Analyst & Investor Event at 2017 ASCO Annual Meeting

    SAN FRANCISCO, April 20, 2017 /PRNewswire/ -- Nektar Therapeutics (NKTR) today announced that it will host an analyst and investor event with clinical investigators on Saturday, June 3, 2017 at 6:00 pm CDT in Chicago, IL during the 2017 American Society of Clinical Oncology (ASCO) Meeting. Presenters will include Dr. Adi Diab, Assistant Professor, Melanoma Medical Oncology at the University of Texas MD Anderson Cancer Center, Dr. Nizar Tannir, Professor, Genitourinary Medical Oncology at the University of Texas MD Anderson Cancer Center and Dr. Michael Hurwitz, Assistant Professor of Medicine (Medical Oncology) at Yale Cancer Center.

  • Motley Fool9 days ago

    How Nektar Therapeutics' Latest Drug Could Shake Up the Market for Pain Medicine

    NKTR-181's ability to tackle back pain potentially positions it for an FDA application for approval.